Beyond the ordinary risk of how successful the interposer will be, which has been priced into the stock since we first heard of Poet’s focus thereon, the perceived length of time to success is holding the stock back. 

As an NR approaches, the faithful bid the stock up, in the hope of good news which includes that the interposer is loved and qualified by soon to be customers.  

But overall, the weak volume for months literally screams (to me, anyway) that we’ve got a ways to go. A well known DL buyer would have mitigated that risk somewhat.  However, we ended up with a relatively unknown buyer, which may well turn out perfectly fine, but adds no current sizzle.  

One also can draw a reasonable inference from the language provided by the filing that the IO has not yet gotten where Poet and customers anticipate it will get. Since 400g is where it’s at, it seems that qualification of that iteration is still a ways off.  

For me, that’s one big reason our market cap is where it is.  

If I’m way off base here, please point out why.  Thanks